NICE, France, June 18 /PRNewswire/ --
- The new Lumax 540 technologies together with BIOTRONIK Home Monitoring(R) offer remote, wireless advanced patient management that provides daily protection for patients with life-threatening arrhythmias.
BIOTRONIK GmbH & Co KG, the pioneer in wireless remote monitoring technology for patients with cardiac devices, announced the launch of the Lumax 540 series today. This technologically advanced series, which includes implantable cardioverter defibrillators (ICDs) and a cardiac resynchronization therapy defibrillator (CRT-D), has many industry-leading features to save and enhance patients' lives. This together with BIOTRONIK Home Monitoring(R) enables continuous automatic daily data transmission of the patient's cardiovascular status. The information is available to the physicians online allowing them to continuously check their patients' cardiac and device status.
"Lumax 540 has an excellent range of high quality features that allow physicians to tailor the treatment to our individual patients. Coupled with the BIOTRONIK Home Monitoring technologies, we are able to access patient data online anywhere in the world," said Professor Panos Vardas, Cardiology Department, University Hospital, Heraklion, Crete, Greece.
The Lumax 540 series has a unique set of state-of-the-art features to
ensure that patients receive the appropriate therapy adapted to their
individual needs while maintaining optimal safety. SelectSense has various
presettings to adapt sensing characteristics to individual patient needs to
ensure accurate arrhythmia detection. The Defibrillation Threshold Manager
ensures that life-saving shock therapy is delivered successfully. In
addition, the Automatic Threshold Monitor performs daily threshold
measurements. The Heart Failure Monitor de
|SOURCE BIOTRONIK GmbH & Co. KG|
Copyright©2008 PR Newswire.
All rights reserved